In an article by Brigantine et al, published in Eur Urol (2012), the authors look at whether adjuvant or salvage radiotherapy is best to achieve prostate cancer cure following radical prostatectomy. This matched case control study of 890 men showed no difference in treating pT3 disease immediately post radical prostatectomy (adjuvant), or treating a rising PSA above 0.2 but below 0.5 ng/ml (salvage). At 2 and 5 years post surgery PSA recurrence free rates were about 91% and 80% in both groups with no statistical difference. Salvage treating reduces the need to treat all high risk men and reduces the morbidity of unnecessary radiotherapy. This is probably the best published evidence addressing this question to date, but the results of a randomised trial is awaited.
I didnt look for this, but I really like this, found it inspiring! Keep up the great work!
I found something like this elsewhere and really loved. Some more of this please! Thank you
Thank you for sharing superb informations. Your website is so cool. I’m impressed by the details that you’ve on this blog. It reveals how nicely you understand this subject. Bookmarked this website page, will come back for extra articles. You, my pal, ROCK! I found simply the info I already searched everywhere and just could not come across. What a great web site.
Not what I was expecting but awesome anyway! Nice one!
Great post. I am a normal visitor of your website and appreciate you taking the time to maintain the nice site. I’ll be a regular visitor for a long time.
Hi there, just became alerted to your blog through Google, and found that it is truly informative. I’ll be grateful if you continue this in future. Lots of people will be benefited from your writing. Cheers!
Hi there, just became alerted to your blog through Google, and found that it is really informative. I will appreciate if you continue this in future. Lots of people will be benefited from your writing. Cheers!
But wanna remark that you have a very nice site, I like the design and style it really stands out.